Impact of Smoking and Smoking Cessation Medications in Aviators.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Dailey JI;Dailey JI;Dailey JI; Wilson KC; Wilson KC
  • Source:
    Current psychiatry reports [Curr Psychiatry Rep] 2019 Nov 20; Vol. 21 (12), pp. 127. Date of Electronic Publication: 2019 Nov 20.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Current Science Country of Publication: United States NLM ID: 100888960 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-1645 (Electronic) Linking ISSN: 15233812 NLM ISO Abbreviation: Curr Psychiatry Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: Philadelphia, PA : Current Science, c1999-
    • Subject Terms:
    • Abstract:
      Purpose of Review: To (1) compare the effects of cigarette smoking, nicotine withdrawal, and smoking cessation medications in US civilian and military aviators and (2) review the regulations in place regarding the use of smoking cessation medications for US aviators.
      Recent Findings: Cigarette smoking and associated cessation attempts are associated with multiple hazards in flight to aviators including effects from nicotine intoxication, nicotine withdrawal, carbon monoxide intoxication, and side effects related to smoking cessation medications. Current civilian and military regulations place significant restrictions on the use of smoking cessation medications to aviators; however, recent research suggests that the hazards associated with these medications might be lower than the risk-associated unassisted nicotine withdrawal. An evidence-based approach to smoking cessation may require changing restrictions against smoking cessation medication use in US civilian and military aviators. Use and cessation of smokeless tobacco and e-cigarettes require additional attention and research in this population.
    • References:
      J Am Coll Cardiol. 1993 Dec;22(7):1881-6. (PMID: 8245343)
      Aviat Space Environ Med. 2005 Nov;76(11):1064-7. (PMID: 16313143)
      Aviat Space Environ Med. 1995 Feb;66(2):164-7. (PMID: 7726782)
      Neuropsychopharmacology. 2003 Jul;28(7):1366-73. (PMID: 12784106)
      Aviat Space Environ Med. 2003 Mar;74(3):247-51. (PMID: 12650272)
      Psychopharmacology (Berl). 1992;108(4):432-6. (PMID: 1410154)
      Psychopharmacology (Berl). 1998 Nov;140(1):38-41. (PMID: 9862400)
      Lancet. 2016 Jun 18;387(10037):2507-20. (PMID: 27116918)
      Aviat Space Environ Med. 2010 Jul;81(7):660-4. (PMID: 20597245)
      MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464. (PMID: 28056007)
      Addict Behav. 2018 Jan;76:129-134. (PMID: 28802179)
      Aviat Space Environ Med. 1978 Jun;49(6):785-91. (PMID: 656005)
      Circulation. 1998 Aug 11;98(6):528-34. (PMID: 9714109)
      Aviat Space Environ Med. 1987 Aug;58(8):777-82. (PMID: 3632538)
      Aviat Space Environ Med. 2009 Jan;80(1):29-59. (PMID: 19180856)
      Annu Rev Pharmacol Toxicol. 1996;36:597-613. (PMID: 8725403)
      Nicotine Tob Res. 2007 Mar;9(3):329-39. (PMID: 17365765)
      Mil Med. 2018 Mar 1;183(3-4):e165-e170. (PMID: 29365191)
    • Contributed Indexing:
      Keywords: Aviation; Bupropion; Nicotine; Smoking cessation; Varenicline
    • Accession Number:
      0 (Nicotinic Agonists)
      0 (Smoking Cessation Agents)
      01ZG3TPX31 (Bupropion)
    • Publication Date:
      Date Created: 20191122 Date Completed: 20200528 Latest Revision: 20200528
    • Publication Date:
      20221213
    • Accession Number:
      10.1007/s11920-019-1109-x
    • Accession Number:
      31748911